z-logo
open-access-imgOpen Access
Complications of Pancreatic Cancer Resection
Author(s) -
Christopher Halloran,
Paula Ghaneh,
L. Bosonnet,
Mark Hartley,
Robert Sutton,
John P. Neoptolemos
Publication year - 2002
Publication title -
digestive surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.762
H-Index - 69
eISSN - 1421-9883
pISSN - 0253-4886
DOI - 10.1159/000052029
Subject(s) - medicine , octreotide , pancreatic cancer , pancreatic fistula , mortality rate , surgery , complication , periampullary cancer , incidence (geometry) , cancer , pancreaticoduodenectomy , general surgery , fistula , resection , somatostatin , pancreas , physics , optics
Pancreatic cancer is a common cause of cancer death in the developed world. Currently, resection is the only chance of long-term survival. The post-operative mortality in nonspecialist centres often exceeds 20% but is around 6% or less in specialist centres. The overall complication rate even in specialist centres is 18-54%. An analysis of eleven large series of pancreatic resections shows an incidence of common complications of 10.4% for fistula, 9.9% for delayed gastric emptying, 4.8% for bleeding, 4.8% for wound infection and 3.8% for intra-abdominal abscess. The median hospital stay is 13-18 days in different series. The re-operation rate varies from 4 to 9% with a mortality rate of 23 to 67%. Major complications are a significant factor in post-operative mortality, especially if they require re-operation. The use of octreotide or somatostatin to prevent complications is supported by several multicentre, double-blind, randomized controlled trials. The best way to improve outcome is to concentrate pancreatic cancer care in regional specialist centres.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here